"De-escalation" strategy using micafungin for the treatment of systemic Candida infections: budget impact in France and Germany

• 主要な著者: van Engen A (著者), Casamayor M (著者), Kim S (著者), Watt M (著者), Odeyemi I (著者)
• フォーマット: 図書
• 出版事項: Dove Medical Press, 2017-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Anke van Engen,1 Montserrat Casamayor,2 Soyoung Kim,3 Maureen Watt,4 Isaac Odeyemi4 1Quintiles Consulting, Hoofddorp, the Netherlands; 2Quintiles Consulting, Barcelona, Spain; 3Astellas Pharma Singapore Pte., Singapore; 4Astellas Pharma Inc., Chertsey, UK Background: The incidence of azole-resistant...